| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9512 |
| Human Intestinal Absorption | HIA+ | 0.9934 |
| Caco-2 Permeability | Caco2+ | 0.9091 |
| P-glycoprotein Substrate | Non-substrate | 0.8008 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9896 |
| Non-inhibitor | 0.9932 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9177 |
| Distribution |
| Subcellular localization | Mitochondria | 0.6943 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.7379 |
| CYP450 2D6 Substrate | Non-substrate | 0.9630 |
| CYP450 3A4 Substrate | Non-substrate | 0.8100 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.8782 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9780 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9674 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9918 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9775 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9875 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9665 |
| Non-inhibitor | 0.9868 |
| AMES Toxicity | Non AMES toxic | 0.9947 |
| Carcinogens | Non-carcinogens | 0.5746 |
| Fish Toxicity | High FHMT | 0.7297 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9168 |
| Honey Bee Toxicity | High HBT | 0.7028 |
| Biodegradation | Ready biodegradable | 0.8428 |
| Acute Oral Toxicity | III | 0.6756 |
| Carcinogenicity (Three-class) | Non-required | 0.7505 |